Diuretics as initial and sole treatment in chronic cardiac failure
- PMID: 1760518
Diuretics as initial and sole treatment in chronic cardiac failure
Abstract
Six patients with chronic congestive cardiac failure, who had never received any drug treatment, were studied before and after one month of therapy with frusemide alone at a dose of 40 mg a day. Measurements were made at rest of plasma epinephrine, norepinephrine, renin activity, aldosterone, atrial natriuretic peptide, cortisol, growth hormone and prolactin, together with central hemodynamics, body fluid volumes and renal function. The initial measurements of hemodynamics, body fluid compartments and renal function confirmed the presence of the physiopathology typical of congestive cardiac failure. Plasma concentrations of norepinephrine, atrial natriuretic peptide, aldosterone and growth hormone were significantly increased. The mean value of plasma renin activity, although high, was not significantly different from normal. After one month of treatment, body weight, body fluid volumes and exchangeable sodium were reduced. Hemodynamics and renal plasma flow and glomerular filtration were not significantly affected. Plasma norepinephrine fell to within normal limits; atrial natriuretic peptide increased significantly; plasma renin activity and cortisol increased to levels which were abnormally high; growth hormone increased to levels similar to those associated with acromegaly. Increased circulating concentrations of atrial natriuretic peptide during treatment by frusemide may have an important influence on the kidney, blood vessels and neuro-endocrine response.
Similar articles
-
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.Circulation. 2004 Apr 6;109(13):1680-5. doi: 10.1161/01.CIR.0000124064.00494.21. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023890
-
Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.Circ Heart Fail. 2009 Nov;2(6):532-40. doi: 10.1161/CIRCHEARTFAILURE.109.861336. Epub 2009 Sep 22. Circ Heart Fail. 2009. PMID: 19919977
-
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.Circ Heart Fail. 2009 Nov;2(6):523-31. doi: 10.1161/CIRCHEARTFAILURE.108.798389. Epub 2009 Sep 24. Circ Heart Fail. 2009. PMID: 19919976 Clinical Trial.
-
[Role of prostaglandins in regulation of kidney function in heart failure].Herz. 1991 Apr;16(2):116-23. Herz. 1991. PMID: 2066053 Review. German.
-
The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.Eur Heart J. 1988 Feb;9(2):132-41. doi: 10.1093/oxfordjournals.eurheartj.a062466. Eur Heart J. 1988. PMID: 2832173 Review.
Cited by
-
Haemodynamic effects of diuretics in heart failure.Br Heart J. 1994 Aug;72(2 Suppl):S44-7. doi: 10.1136/hrt.72.2_suppl.s44. Br Heart J. 1994. PMID: 7946758 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical